Erratum to "Parvovirus B19 infection in pregnancy" [J. Clin. Virol. 36 (2006) 1-7] (DOI:10.1016/j.jcv.2006.01.004);Parvovirus B19 infection in pregnancy

Journal of Clinical Virology

Volumn 36, Issue 1, 2006, Pages 1-7

  de Jong, Eveline P ^a   de Haan, Timo R ^a   Kroes, Aloys C M ^a   Beersma, Matthias F C ^a   Oepkes, Dick ^a   Walther, Frans J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fetal anemia; Intrauterine infection; Intrauterine transfusion; Parvovirus B19

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; SINGLE STRANDED DNA; VIRUS DNA;

ANEMIA; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; CLINICAL FEATURE; CYTOTOXICITY; DELIVERY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ERYTHEMA INFECTIOSUM; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FETUS DEATH; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS HYDROPS; FETUS MONITORING; FETUS OUTCOME; FLOW RATE; GENETIC IDENTIFICATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTRAUTERINE BLOOD TRANSFUSION; INTRAUTERINE INFECTION; LABOR INDUCTION; MATERNAL SERUM; MIDDLE CEREBRAL ARTERY; NEUROLOGIC DISEASE; NON INVASIVE PROCEDURE; PATHOGENESIS; PATIENT CARE; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SERODIAGNOSIS; SYSTOLIC BLOOD PRESSURE; VIROLOGY; VIRUS TRANSMISSION; DISEASE TRANSMISSION; ECHOGRAPHY; FEMALE; NEWBORN; PARVOVIRUS; PREGNANCY COMPLICATION; VIRUS INFECTION;

ANEMIA; BLOOD TRANSFUSION, INTRAUTERINE; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 33744522646     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2006.11.001     Document Type: Erratum

References (45)

1. Anderson M.J., Higgins P.G., Davis L.R., Willman J.S., Jones S.E., Kidd I.M., et al. Experimental parvoviral infection in humans. J Infect Dis 152 (1985) 257-265
2. Ballou W.R., Reed J.L., Noble W., Young N.S., and Koenig S. Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1. J Inf Dis 187 (2003) 675-678
3. Beersma M.F.C., Claas E.C.J., Sopaheluakan T., and Kroes A.C.M. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol 34 (2005) 71-75
4. Bond P.R., Caul E.O., Usher J., Cohen B.J., Clewley J.P., and Field A.M. Intrauterine infection with human parvovirus. Lancet 1 (1986) 448-449
5. Bosman A., Wallinga J., and Kroes A.C.M. Fifth disease every four years: parvovirus B19. Infectieziektenbulletin 6 (2002) 215-219. http://www.rivm.nl/infectieziektenbulletin/bul1306/parvo.html Accessible at:
6. Brown T., Anand A., Ritchie L.D., Clewley J.P., and Reid T.M.S. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 2 (1984) 1033-1034
7. Cartter M.L., Farley T.A., Rosengren S., Quinn D.L., Gillespie S.M., Gary G.W., et al. Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis 163 (1991) 282-285
8. Chisaka H., Morita E., Yaegashi N., and Sugamura K. Parvovirus B19 and the pathogenesis of anemia. Rev Med Virol 13 (2003) 347-359
9. Cohen B.J., and Kumar S. Parvovirus B19 infection in pregnancy. Fetal Matern Med Rev 16 (2005) 123-150
10. Cosmi E., Mari G., Delle Chiaie L., Detti L., Akiyama M., Murphy J., et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 187 (2002) 1290-1293
11. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 11 (1975) 72-73
12. Craze J.L., Salisbury A.J., and Pike M.G. Prenatal stroke associated with maternal parvovirus infection. Dev Med Child Neurol 38 (1996) 84-85
13. De Haan T.R., Oepkes D., Beersma M.F.C., and Walther F.J. Aetiology, diagnosis and treatment of hydrops foetalis. Current Pediatr Rev 1 (2005) 63-72
14. Delle Chaie L., Buck G., Grab D., and Terinde R. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection. Ultrasound Obstet Gynecol 18 (2001) 232-236
15. Dembinski J., Haverkamp F., Maara H., Hansmann M., Eis-Hübinger A.M., and Bartmann P. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19-induced fetal hydrops. Br J Obstet Gynaecol 109 (2002) 1232-1234
16. Dembinski J., Eis-Hübinger A.M., Maar J., Schild R., and Bartman P. Long term follow up of serostatus after maternofetal parvovirus B19 infection. Arch Dis Child 88 (2003) 219-221
17. Doyle S., Kerr S., O'Keeffe G., O'Carroll D., Daly P., and Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 90 (2000) 143-152
18. Enders M., Weidner A., Zoellner I., Searle K., and Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 24 (2004) 513-518
19. Fairley C.K., Smoleniec J.S., Caul O.E., and Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 346 (1995) 1335-1337
20. Gillespie S.M., Cartter M.L., Asch S., Rokos J.B., Gary G.W., Tsou C.J., et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA 263 (1990) 2061-2065
21. Gray E.S., Anand A., and Brown T. Parvovirus infections in pregnancy. Lancet 1 (1986) 208
22. Guidi B., Bergonzini P., Crisi G., Frigieri G., and Portolani M. Case of stroke in a 7-year-old male after parvovirus B19 infection. Pediatr Neurol 28 (2003) 69-71
23. Harger J.H., Adler S.P., Koch W.C., and Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 91 (1998) 413-420
24. Heegaard E.D., and Brown K.E. Human parvovirus B19. Clin Microbiol Rev 15 (2002) 485-505
25. Isumi H., Nunoue T., Nishida A., and Takashima S. Fetal brain infection with human parvovirus B19. Pediatr Neurol 21 (1999) 661-663
26. Jordan J.A. Diagnosing human parvovirus B19 infection: guidelines for test selection. Mol Diagn 6 (2001) 307-312
27. Jordan J.A., and DeLoia J.A. Globoside expression within the human placenta. Placenta 20 (1999) 103-108
28. Kaufmann B., Simpson A.A., and Rossmann M.G. The structure of human parvovirus B19. PNAS 101 (2004) 11628-11633
29. Kawase M., Momoeda M., Young N.S., and Kajigaya S. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 211 (1995) 359-366
30. Kerr J.R., Barah F., Chiswick M.L., McDonnell G.V., Smith J., Chapman M.D., et al. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J Neurol Neurosurg Psychiatr 73 (2002) 739-746
31. Koch W.C., Harger J.H., Barnstein B., and Adler S.P. Serologic and virologic evidence for frequent intrauterine transmission of human parvovirus B19 with a primary maternal infection during pregnancy. Pediatr Infect Dis J 17 (1998) 489-494
32. Lindblom A., Isa A., Norbeck O., Wolf S., Johansson B., Broliden K., et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 41 (2005) 1201-1203
33. Lukashov V.V., and Goudsmit J. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J Virol 75 (2001) 2729-2740
34. Mandrioli J., Portolani M., Cortelli P., and Sola P. Middle cerebral artery thrombosis in course of parvovirus B19 infection in a young adult: a new risk factor for stroke?. J Neurovirol 10 (2004) 71-74
35. Moffat S., Yaegashi N., Tada K., Tanaka N., and Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol 72 (1998) 3018-3028
36. Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J., Kodera T., Ishii T., et al. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106 (2005) 3449-3456
37. Norbeck O., Papadogiannakis N., Petersson K., Hirbod T., Broliden K., and Tolfvenstam T. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis 35 (2002) 1032-1038
38. Rodis J.F., Rodner C., Hansen A.A., Borgida A.F., Deoliveira I., and Shulman Rosengren S. Long-term outcome of children following maternal human parvovirus B19 infection. Obst Gynecol 91 (1998) 125-128
39. Schild R.L., Bald R., Plath H., Eis-Hübinger A.M., Enders G., and Hansmann M. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 13 (1999) 161-166
40. Trotta M., Azzi A., Meli M., Borchi B., Periti E., Pontello V., et al. Intrauterine parvovirus B19 infection: early prenatal diagnosis is possible. Int J Infect Dis 8 (2004) 130-131
41. Valeur-Jensen A.K., Pedersen C.B., Westergaard T., Jensen I.P., Lebech M., Andersen P.K., et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA (1999) 1099-1105
42. Van Kamp I.L., Klumper F.J.C.M., Bakkum R.S.L.A., Oepkes D., Meerman R.H., Scherjon S.A., et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 185 (2001) 668-673
43. Weigel-Kelley K.A., Yoder M.C., and Srivastava A. α5β1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of β1 integrin for viral entry. Blood 102 (2003) 3927-3933
44. Yaegashi N., Niinuma T., Chisaka H., Watanabe T., Uehara S., Okamura K., et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J Infect 37 (1998) 28-35
45. Young N.S., and Brown K.E. Mechanics of disease: parvovirus B19. N Engl J Med 350 (2004) 586-597